We hypothesized that dual IL-2R and α4β7/MAdCAM-1 axis blockade may further improve the clinical outcomes of patients with SR-LGI-GVHD and have an acceptable level of infection. The gene discussed is MADCAM1; the disease is graft versus host disease.